Big, fat demand for weight-loss drugs fuels Eli Lilly stock surge — as market cap hits $1.2 trillion
Top Story
Archived
•
October 29, 2026
•
2 views
Eli Lilly stock hit a record high Thursday thanks to a stronger-than-expected earnings report fueled by sales of weight loss drugs Monjuaro and Zepbound.
Source: New York Post | https://nypost.com/feed/ - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



